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Abstract 
Brain-Derived Neurotrophic Factor and Maternal Behavior: 
Neuronal Alterations in the Medial Preoptic Area and Suppression of Pup Attacks 
Lillian Flores Stevens 
Master of Arts in Psychology, 2003 
University of Richmond 
Thesis Director: Dr. Craig H. Kinsley 
Brain-derived neurotrophic factor (BDNF), by virtue of its relationship to various 
neurotransmitter systems, hormones, and to estrogen in particular, may play a role in 
maternal behavior. To explore this possible role, female virgin Sprague Dawley rats 
received continuous intracerebroventricular infusions ofBDNF sense oligonucleotide and 
were exposed to pups for maternal behavior testing. Behaviorally, BDNF sense had no 
effect on maternal behavior but did significantly suppress pup attacks during the first 24 
hours of exposure. BDNF had a significant effect on neuronal morphology in the medial 
preoptic area (mPOA) as well, such that neurons in this region exposed to BDNF had 
more dendritic protrusions per 10 µm of dendritic branch than did control neurons. 
However, the length of the two longest dendritic spines on each branch measured was not 
affected. These findings shed light on the differential effects of BDNF in both priming 
the mPOA for behavior to occur, and in suppressing a specific aspect of maternal 
behavior. 
I certify that I have read this Thesis and find that, in scope and quality, it 
satisfies the requirements for the degree of Master of Arts. 
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BDNF & Maternal Behavior 1 
Brain-Derived Neurotrophic Factor and Maternal Behavior: 
Neuronal Alterations in the Medial Preoptic Area and Suppression of Pup Attacks 
A female experiences a myriad of changes, both physical and behavioral, as she 
progresses through pregnancy, parturition, lactation and caring for her offspring. The 
exact extent of this transformation's effects, and the mechanisms through which it occurs, 
continue to intrigue researchers today. The regulation of maternal behavior is one such 
aspect that is still being explored. In particular, how is maternal behavior correlated to the 
physical changes in the brain? Can brain chemicals, other than hormones, affect this 
behavior? 
Researchers, in pursuit of these and many other questions, are beginning to shed 
light on just how reproductive experience affects a female. In addition to hormonal 
changes, research has indicated that rats with reproductive experience (RE) also 
experience behavioral changes related to learning and memory (Kinsley, Madonia, 
Gifford, Yureski, Griffin, Lowry, et al., 1999). These data show that rats with RE are 
capable of learning to run a radial-arm maze and dry land version of the Morris water 
maze more quickly and with fewer errors than their nulliparous (virgin) counterparts. 
These results have been extended to the right angle maze; another test of spatial ability 
(Kinsley et al., 1999). 
The behavioral changes may be related to simultaneous neuronal changes in the 
rats. In late pregnant females there is increased dendritic spine proliferation in the CAI 
area of the hippocampus (an area of the brain associated with learning and memory), 
which may allow for more connections to adjacent neurons (Trainer, Quadros, Stafisso-
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Sandoz, & Kinsley, 1997; Kinsley, Trainer, Quadros, & Stafisso-Sandoz, 1998). Also, 
glial cells, those cells that support neurons and provide nourishment, show increased 
number and complexity in the hippocampus and in the medial preoptic area, an area of 
the brain associated with regulating maternal behavior (Gifford, Miller, Quadros, 
Lambert, & Kinsley, 1998). These glial changes may indicate a similar increased 
complexity in the neurons in these brain regions. There have also been observed 
enhancements ofneurogenesis (new neuron growth) in the postpartum period, following 
a significant reduction of neurogenesis during pregnancy as well as the dip of hormones 
inherent in parturition (Amory & Madonia, unpublished observations). 
Evidence suggests that the aforementioned neuronal changes come about via the 
effects of estrogen. Estrogen is known to promote dendritic spine growth and synaptic 
plasticity. As McEwen and Woolley (1994) explain, an increase in number of spines is 
accompanied by an increase in the number of synapses, thus more connections to 
adjacent neurons. More specifically, dendritic arborization (the tree-like projection of 
dendrites) and synapse formation increase and decrease rapidly during the rat's 5-day 
estrous cycle (Woolley, Gould, Frankfurt, & McEwen, 1990; Woolley & McEwen, 1992; 
Woolley & McEwen, 1993; McEwen, Alves, Bulloch, & Weiland, 1997). This waxing 
and waning can be reproduced by giving estradiol to ovariectomized rats for several days 
(Woolley & McEwen, 1993; McEwen & Woolley, 1994). Estrogen replacement therapy 
has also been shown to increase the number of neurites (also referred to as dendrites), 
neurite length, total number of branches, and branch length (Brinton, Chen, Montoya, 
Hsieh, & Minaya, 2000). 
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Interestingly, estrogen deprivation has been reported as a significant factor 
affecting nonspatial learning in animals (Singh, Meyer, Millard, & Simpkins, 1994) and 
humans (Asthana, Baker, Craft, Stanczyk, Veith, Raskind, et al., 2001). Singh and 
colleagues ( 1994) reported an impairment of active avoidance learning after as little as 5 
weeks of estrogen deprivation in female rats. Further, Asthana and colleagues (2001) 
worked with postmenopausal women with Alzheimer's disease and reported that short-
term administration of estrogen improved verbal memory, visual memory and attention. 
The previously described findings regarding how maternal experiences affect the 
brain and behavior, however, also bear remarkable similarity to the effects ofbrain-
derived neurotrophic factor (BDNF)- a protein that is primarily responsible for promoting 
neuron survival, enhancing dendritic sprouting, providing neuronal protection against 
insult, and enhancing recovery of damaged neurons (Kesslak, So, Choi, Cotman, & 
Gomez-Pinilla, 1998). As previously mentioned, estrogen, too, increases dendritic 
sprouting. These neuronal changes lead to stronger, healthier neurons that are better able 
to connect with more neurons and thus increase intercellular communication. Better 
neuronal communication also enhances learning. 
BDNF is thus closely linked to estrogen by its similar neuroprotective effects, and 
has been implicated in learning and memory (Kesslak, So, Choi, Cotman, & Gomez-
Pinilla, 1998). It is therefore possible that the behavioral effects reported in rats with 
reproductive experience are in some way related to the levels of BDNF in the brain. 
Further, multiparous rats have been shown to exhibit less BDNF immunoreactivity in the 
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hippocampus- particularly in the CA3 area (Lambert, Love, Stevens, McNamara, 
Morgan, Hoffman, et al., 2003). 
The knowledge that BDNF is implicated in neuronal and behavioral learning 
changes (which our laboratory has reported in rats with reproductive experience) points 
strongly toward the involvement of BDNF in the enhancement of learning and memory in 
rats with reproductive experience. This study will attempt to further explore the potential 
role ofBDNF in stimulating maternal behavior, a behavior "learned" by virgin rats 
through exposure to pups. A brief review of background and related literature is 
provided. 
The Transformation From Virgin to Motherhood and Beyond 
A nulliparous female experiences constant hormonal fluctuations during the 
estrous cycle. Estrogen levels are low during estrus, begin to rise from metestrus through 
the morning of di estrus, reach peak concentrations by the afternoon of proestrus and fall 
rapidly reaching basal levels by early estrus (Freeman, 1994). Progesterone peaks twice 
during the cycle- the first peak occurs during the afternoon and evening of proestrus 
(when estrogen levels peak). A second larger peak begins midway through metestrus and 
lasts through early morning of diestrus and falls to basal levels shortly thereafter 
(Freeman, 1994). Please see Figure 1. 
During pregnancy, the female experiences a sustained change in hormonal levels 
Numan (1994). Estradiol levels are relatively low until day 16 of pregnancy, after which 
they begin to rise and reach peak levels on day 22. Progesterone levels are relatively high 
through out pregnancy as well, reaching peak levels on days 14 and 15. They begin to 
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decline sharply beginning on day 19. During the first half of pregnancy, prolactin, a 
lactogenic hormone that stimulates mammary gland development, is secreted from the 
anterior pituitary in two daily surges, but in the second half of pregnancy prolactin levels 
are low. A final peak occurs in the last two days of pregnancy. Oxytocin, a hormone 
involved in causing uterine contractions, keeps relatively low levels throughout the 
pregnancy, but increases sharply as parturition nears. Please see Figure 2. 
Russell, Douglas and Ingram (2001) summarize how the hormones of pregnancy 
affect the female physiologically in a number of ways. She experiences a suppression of 
fertility and metabolic changes that include a 40% increase in blood volume, and an 
increase in body weight, fluids and adipose tissue. The female's hypothalamo-pituitary-
adrenal (HPA) axis is modified as well, which in tum affects metabolism, gene 
transcription, and lowers responses to stress and fear. Further, there is reduced excitation 
in the limbic brain regions that process stressors during pregnancy and lactation. 
Relatedly, Wartella, Amory, Macbeth, Stevens, Lambert and Kinsley (2003, 
article in press) found that parous and gravid females not only displayed reduced stress 
reactivity in an open field maze, but also reduced c-fos activation in the CA3 of the 
hippocampus and in the basolateral amygdala. Further work by McNamara, Love, 
Lambert and Kinsley (2003) is extending this line of research by examining stress 
reactivity throughout the lifespan. Nulliparous, primiparous and multiparous females 
have so far been tested on an elevated plus maze at 6, 9 and 12 months of age. Results 
show that at six months there was no difference in anxiety, with all groups showing equal 
time on the open arm. However, by 9 months the primiparous were spending significantly 
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more time on the open arm (displaying less anxiety). The multiparous females spent less 
time on the open arm than the primiparous, and the nulliparous females spent the least 
amount of time on the open arm. Similar results have been seen at 12 months, with 
primiparous females displaying the least anxiety. However, the multiparous and 
nulliparous females were not significantly different from each other, but the trend was 
similar to that seen at 9 months. Future tests will be conducted as the rats get older. Both 
these studies reiterate the lower stress reactivity of females with reproductive experience. 
The hormonal patterns of pregnancy not only affect the female physiologically, 
but behaviorally as well. Perhaps the most characteristic change in behavior that the 
hormones of pregnancy (prolactin and oxytocin in particular) exert on the postpartum 
female rat is that of the immediate onset of maternal behavior (Keyser-Marcus, Stafisso-
Sandoz, Gerecke, Jasnow, Nightingale, Lambert, et al., 2001). Mothers engage in pup-
directed behaviors such as constructing elaborate nests, retrieving, grouping, crouching 
and licking their pups. They also sleep and eat in different patterns than before parturition 
and forage more efficiently (Keyser-Marcus et al., 2001). 
These behaviors during lactation are maintained by a combination of hormones 
and pup stimulation. Suckling stimulation causes the release of the hormones necessary 
for lactation and milk ejection; these include prolactin, growth hormone, and 
adrenocorticotropic hormone from the anterior pituitary and oxytocin from the 
neurohypophysis (Numan, 1994). Sucking stimulation also inhibits the release of 
gonadotropic hormones, which results in the suspension of ovulation. Further, as the pups 
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grow older, they elicit less maternal responsiveness. If younger pups continuously 
replace older pups, maternal responsiveness is prolonged (Numan, 1994). 
However, the hormones of pregnancy also have long lasting effects that extend 
beyond maternal behavior. As was already mentioned, rats with RE have increased 
spatial abilities (Kinsley et al., 1999). Gatewood (2002) extended these findings by 
testing nulliparous, primiparous and multiparous females in a dry land maze 
longitudinally at 6, 12, 18 and 24 months of age. All the parous animals had had their 
reproductive experience before testing began. Gatewood found that at all ages, the 
multiparous animals performed the best, followed by the primiparous. Nulliparous 
females performed the worst. Her findings show a spatial learning improvement for 
parous animals that lasts through senescence. 
Brain-Derived Neurotrophic Factor 
Neurotrophins are proteins that regulate the survival (protection from metabolic 
insult, brain injury, apoptosis, etc.), differentiation, and plasticity (ability to change in 
both shape and physiology) of neurons (Berninger & Poo, 1999) by causing rapid 
changes in neuron morphology and physiology (McAllister, Katz, & Lo, 1999). They can 
be thought of as intercellular messengers (mainly neuron to neuron communication), 
which are used by neurons to regulate the gene expression of their innervating neurons 
(Smith, 1996). They also modulate and mediate chemical transmission at certain synapses 
by causing membrane depolarization and can modulate the secretion of neurotransmitter-
filled vesicles (Berninger & Poo, 1999). 
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Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin 
family, and is one of the most widely expressed in the brain (Fumagalli, Santero, 
Gennarelli, Racagni, & Riva, 2001 ). As gathered from studies in rodents, BDNF is 
expressed in many brain areas, including the hippocampus, dentate gyrus, amygdala, 
projection areas of the olfactory system, inner and outer pyramidal layers of the 
neocortex (Phillips, Hains, Laramee, Rosenthal, & Winslow, 1990), claustrum, 
cerebellum, and the superior colliculus (Hofer, Paglusi, Hohn, Leibrock, & Barde, 1990; 
Wetmore, Emfors, Persson, Olson, 1990). 
Within the brain, as described by Murer, Boissiere, Yan, Hunot, Villares, 
Raucheux, et al. (1999), BDNF immunoreactivity was observed in the cytoplasm of 
neuronal cell bodies and proximal dendrites, axons and nerve terminals, in glial cells and 
processes, as well as in senile plaques of patients with Alzheimer's disease. 
BDNF, as previously mentioned, is primarily responsible for promoting neuron 
survival, enhancing dendritic sprouting, providing neuronal protection against insult, and 
enhancing recovery of damaged neurons (Kesslak, So, Choi, Cotman, & Gomez-Pinilla, 
1998). It is also involved in a myriad of other neuronal events. For example, BDNF plays 
a role in the formation and maintenance of long-term potentiation in the hippocampus 
(Korte, Carroll, Wolf, Brem, Thoenen, & Bonhoeffer, 1995; Johnson, 1999), promotes 
activity-dependent dendritic growth (McAllister, Katz, & Lo, 1996), provides protection 
from apoptotic cell death (Courtney, Akerman, & Coffey, 1997), promotes survival of 
motor neurons (Jessell & Sanes, 2000), is involved in synaptic plasticity in the adult 
central nervous system (Hall, Thomas, & Everitt, 2000), mediates glial development 
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(Pruginin-Bluger, Shelton, & Kalcheim, 1997), and modulates myelination in the 
peripheral nervous system (Chan, Cosgaya, Wu, & Shooter, 2001). 
Additionally, BDNF can enhance the release of various neurotransmitters 
(Thoenen, 1995), and in fact, BDNF can modulate the opening of a sodium channel on 
the same timescale as a change in voltage can (Barde, 2002). Further, BDNF is involved 
in various forms in many different neuronal systems. For example, BDNF has been 
linked to the GABAergic system. GABA is the most important inhibitory 
neurotransmitter in the brain. BDNF has been implicated in contributing to the 
differentiation of GABAergic neurons (Mizuno, Carnahan, & Nawa, 1994), and has been 
shown to enhance the survival, amount of GABA uptake, and total protein content of 
forebrain cholinergic neurons (Kniisel, Winslow, Rosenthal, Burton, Seid, Nikolics, et al. 
1991). BDNF also regulates GABAA receptors (Tanaka, Saito, & Matsuki, 1997) by 
decreasing their number in the postsynaptic membrane (Briinig, Penschuck, Berninger, 
Benson, & Fritschy, 2001). 
GABA is known to decrease BDNF mRNA levels, whereas reciprocally, 
glutamate has been shown to increase BDNF synthesis (Zafra, Castren, Thoenen, & 
Lindholm, 1991; Lindholm, Castren, Berzaghi, Blochl, & Thoenen, 1994). BDNF has 
also been reported to elicit the same excitatory effects (depolarization) as glutamate, but 
at much lower concentrations (Kafitz, Rose, Thoenen, & Konnerth, 1999). Further, 
BDNF enhances glutamate release through the use of intracellular calcium stores 
(Matsumoto, Numakawa, Adachi, Yokomaku, Yagamishi, Takei, et al., 2001). 
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BDNF stimulates the differentiation of cholinergic neurons (Kniisel et al., 1991; 
Nonomura & Hatanaka, 1992), and protects serotonergic neurons from injury and 
promotes their axonal sprouting (Mamounas, Blue, Siuciak, & Altar, 1995). BDNF is 
also known to increase the survival of dopaminergic neurons (Hyman, Hofer, Barde, 
Juhasz, Yancopoulos, Squinto, et al., 1991), and protect dopamine-producing neurons 
from dopamine neurotoxins (Spina, Squinto, Miller, Lindsay, & Hyman, 1992). In its 
target neurons, BDNF elicits long-term neuronal adaptations by inducing the expression 
of D3 dopamine receptors (Guillin, Diaz, Carroll, Griffon, Schwartz, & Sokoloff, 2001). 
It has also been suggested that stressful and challenging situations involving activation of 
the dopaminergic system, and higher than normal release of dopamine, results in a 
reduction ofBDNF expression which leads to an increased cellular vulnerability to stress-
as the neuroprotection provided by BDNF is lacking (Fumagalli, Santero, Gennarelli, 
Racagni, & Riva, 2001 ). 
In addition to exerting an influence, BDNF itself is also influenced by a number 
of events. For example, events that are capable of inducing long-term potentiation (a 
long-term increase in the excitability of a neuron) in the hippocampus, such as 
physiological activity and high frequency stimulation, also increase the levels ofBDNF 
messenger ribonucleic acid (mRNA: the half of the genetic code that contains the signal 
to produce BDNF; Patterson, Grover, Schwartzkroin, & Bothwell, 1992; Poo, 2001). 
High frequency neuronal activity and synaptic transmission can elevate the number of 
trkB receptors (the tyrosine kinase receptor that BDNF binds to with the highest affinity) 
in cultured hippocampal neurons (Du, Feng, Yang, & Lu, 2000), and may therefore 
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facilitate the synaptic action of BDNF (Poo, 2001). Contextual fear training (a process in 
which a negative event such as foot shock is paired to a novel environment) has increased 
hippocampal BDNF expression as well (Hall, Thomas, & Everitt, 2000), yet mild 
stressors such as immobilization stress reduce BDNF levels in the dentate gyrus in as 
little as 45 minutes (Smith, 1996). 
Exercise (voluntary running in rats) can alone modify BDNF mRNA expression 
in the hippocampus and other brain areas (Neeper, Gomez-Pinilla, Choi, & Cotman, 
1995) such that there is enhanced ability of sensory neurons to compensate for insults 
such as sciatic nerve crush injury {Twiss, Molteni, Zheng, Ying, Schanen, & Gomez-
Pinilla, 2002). Molteni, Ying, and Gomez-Pinilla (2002) also reported that in the rat 
hippocampus, BDNF, along with a number of genes involved in synaptic trafficking, 
signal transduction pathways, and transcription regulation, was consistently up-regulated 
during both acute and chronic exercise. These researchers suggest that BDNF plays a 
central role in the effects of exercise on brain plasticity. 
Whereas the effects BDNF has on the brain are well documented, the mechanisms 
by which BDNF works are much less understood. Studies have observed that it is 
transported anterogradely from neuron cell bodies to their terminals (Altar, Cai, Bliven, 
Juhasz, Conner, Acheson, et al., 1997), is released or secreted through presynaptic 
mechanisms in an activity dependent manner (Kohara, Kitamura, Morishima, & 
Tsumoto, 2001), is released on neuron depolarization {Thoenen, 1995), and triggers rapid 
intracellular signals (Altar & DiStefano, 1998) and action potentials in central neurons 
(Kafitz, Rose, Thoenen, & Konnerth, 1999). 
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BDNF has been reported to modulate synaptic vesicle distribution within 
presynaptic terminals in CAI excitatory spine synapses ofhippocampal slices by 
increasing the number of docked vesicles at the active zone (Tyler & Pozzo-Miller, 
2001). Other studies report that BDNF is found in the releasing vesicles in nerve 
terminals (Luo, Rush, & Zhou, 1998, as cited in Mu, Li, Yao, & Zhou, 1999). 
On a related venue, BDNF activates sodium channels via the TrkB receptor; this 
receptor might interact directly or indirectly with the channel protein to cause it to open 
(Berninger & Poo, 1999). Relatedly, calcium channel blockade prevents the upregulation 
ofBDNF (Johnson, 1999), and BDNF mRNA is transiently induced within hours ofa 
voltage sensitive calcium influx (Johnson, 1999). 
The Relationship Between BDNF and Estrogen 
BDNF and estrogen are quite intertwined regarding their effects and functions. 
Both estrogens and neurotrophins "have been shown to promote survival and 
differentiation of their neuronal targets" (Sohrabji, Miranda, & Toran-Allerand, 1995, p. 
11110). The BDNF gene contains an estrogen response element (Sohrabji, Miranda, & 
Toran-Allerand, 1995), and BDNF levels are increased in vivo by estrogen (Singh, 
Meyer, & Simpkins, 1995). BDNF can modulate synaptic transmission, and enhance 
synaptogenesis (McAllister, Katz, & Lo, 1999), just as estrogen can (Woolley & 
McEwen, 1992) .. Further, BDNF is sensitive to regulation by physical activities and 
learning (Neeper, Gomez-Pinilla, Choi, & Cotman, 1995; Kesslak, So, Choi, Cotman, & 
Gomez-Pinilla, 1998), which are also influenced by estrogen levels (McEwen & Alves, 
1999). Berchtold, Kesslak, Pike, Adlard, & Cotman (2001) suggest that some of the 
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beneficial effects of estrogen may be in fact due to increased availability ofBDNF; 
BDNF may provide a pivotal process by which estrogen can exert its positive influence. 
Relatedly, BDNF is significantly affected by physiological changes in the levels 
of gonadal hormones circulating in the body (Gibbs, 1998). Gibbs found that in the CAI, 
CA3 and CA4 regions of the hippocampus, peak levels ofBDNF mRNA were detected 
on the morning of diestrus 2 when progesterone levels are relatively low. At this point 
estrogen levels are undetectable (Y oshinga, Hawkins, & Stocker, 1969). On the other 
hand, the lowest levels ofBDNF mRNA were detected on the afternoon ofproestrus 
when progesterone levels were highest (Gibbs, 1998), and levels of estrogen have peaked 
and begin to decrease (Y oshinga, Hawkins, & Stocker, 1969). 
Also, in a study conducted by Sohrabji et al. (1995), it was found that estrogen 
rapidly up-regulates mRNA expression ofBDNF in the cerebral cortex and olfactory bulb 
of rats. Based on this finding, these researchers suggest that estrogen may be in a position 
to increase the availability ofBDNF by regulating its gene transcription in these areas. 
Studies have reported that deprivation of endogenous estrogen results in reduced 
levels ofBDNF mRNA expression in the hippocampus (Singh et al., 1995; Berchtold, 
Kesslak, Pike, Adlard, & Cotman, 2001). Similarly, estrogen replacement therapy 
increased BDNF mRNA levels in the hippocampus, cerebral cortex, olfactory bulbs, 
medial septum, and the nucleus basalis ofMeynert after this estrogen deprivation (Singh, 
Meyer, & Simpkins, 1995; Sohrabji et al., 1995; Gibbs, 1998). BDNF also remains 
responsive to regulation by exogenous estrogen after 3 weeks of estrogen deprivation 
(Berchtold, Kesslak, Pike, Adlard, & Cotman, 2001). 
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In cultured hippocampal neurons, estradiol down-regulates BDNF, which 
decreases inhibition and increases excitatory tone in pyramidal neurons and increases 
spine density (Murphy, Cole, & Segal, 1998). These same researchers have found that 
exogenous BDNF blocks the effects of estradiol on spine formation and BDNF selective 
antisense oligonucleotide imitates the effect of estradiol. 
Berchtold, Kesslak, Pike, Adlard, & Cotman (2001) report that combined exercise 
and estrogen replacement enhance BDNF gene regulation in the hippocampus above 
replacement alone. 
BDNF's Involvement in Learning and Memory 
BDNF is predominantly expressed in the hippocampus, where it is involved in 
learning and memory (Gibbs, 1998). It has been determined that BDNF expression is 
rapidly and selectively upregulated in the CAI region of the hippocampus during 
contextual learning (Hall, Thomas, & Everitt, 2000). These authors further state that the 
regulation ofBDNF activity is a correlate ofhippocampal learning in vivo. 
Mizuno, Yamada, Olariu, Nawa, & Nabeshima (2000) report that spatial memory 
formation, as tested using the radial arm maze, is associated with an increase in BDNF 
mRNA levels in the hippocampus. These researchers found that antisense BDNF 
oligonucleotide treatment (administering a short chain of nucleotides produced to 
bind to BDNF's particular RNA or DNA sequence and thus block its expression) 
significantly inhibited spatial reference and working memory formation and disrupted 
previously formed spatial memory. 
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Further, Ma, Wang, Wu, Wei, and Lee (1998) found an increase in hippocampal 
BDNF mRNA during the early phase of the memory consolidation process of inhibitory 
avoidance learning. BDNF antisense oligonucleotide injection to the dentate gyrus 
impaired retention performance as well, reduced the amplitude and slope ofLTP, and 
also decreased BDNF mRNA in the dentate gyms. Based on these findings, Ma et al. 
suggest that BDNF gene expression in the hippocampus is a necessary component for 
memory processing and LTP induction in rats. 
Similarly, Mu, Li, Yao, & Zhou (1999) report that BDNF antibody treated rats 
displayed significantly impaired learning and spatial memory abilities, as tested using the 
Morris water maze (a learning task in which a rat is forced to swim to find a submerged 
platform). Upon this finding they suggest that BDNF may be preferentially involved in 
the intermediate steps of the learning process by virtue of its neurotrophic effects on 
cholinergic neurons. 
In 1998 Kesslak, So, Choi, Cotman, and Gomez-Pinilla performed a study to 
investigate the roles that exercise and learning may play in BDNF induction. Using the 
Morris water maze they found that spatial learning enhances expression ofBDNF mRNA 
in addition to the enhancement already caused by the physical activity associated with 
swimming in the maze. Additionally, these elevated levels are maintained with repeated 
exposure. Interestingly, however, intrahippocampal administration ofBDNF does not 
alleviate spatial learning impairments in aged rats (Pelleymounter, Cullen, Baker, Gollub, 
& Wellman, 1996). Pelleymounter et al. did find though, that BDNF induced a partial, 
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long-term normalization of the elevated hypothalamic serotonin levels of these aged 
animals. 
Recent research has established the effects of BDNF on human memory as well. 
Egan, Kojima, Callicott, Goldberg, Kolachana, Bertolino, et al. (2003) studied the effects 
of a valine to methionine substitution in the human BDNF protein. They report that the 
methionine allele was associated with poorer episodic memory and abnormal 
hippocampal activation, as assessed by neuropsychological testing. 
An interesting study by Liu et al. (2000) provides a link between both maternal 
and learning behaviors and the levels of BDNF present in pups. Mother rats were divided 
into groups of high versus low maternal behavior based on their naturally occurring 
variations. The culled litters from mothers displaying high maternal behavior were then 
given to the mothers with low maternal behavior and vice versa, a process called cross-
fostering. The cross-fostered pups from these two groups were studied in terms of various 
neuronal differences, including BDNF levels. Liu and colleagues found increased 
expression ofBDNF mRNA in the dorsal hippocampus of the day 8 pups of high 
maternal behavior rats compared to the pups of low maternal behavior rats. 
Liu and colleagues suggest that variations in maternal behavior cause varying 
sensory experiences for the pups. The amount of maternal licking and grooming each pup 
receives may be different, and the differences in sensory experience may in tum alter the 
pup's levels ofhippocampal synaptic development. These researchers believe that 
maternal care increases N-methyl-D-aspartate receptor (NMDA; receptors to which the 
excitatory neurotransmitter glutamate binds to) levels, which in tum elevates BDNF 
BDNF & Maternal Behavior 17 
expression and increases hippocampal synaptogenesis, which leads to further enhanced 
spatial learning in adulthood. 
However, Roceri, Hendriks, Racagni, Ellenbroek, and Riva (2002) found 
significantly reduced expression of BDNF in the hippocampus of adult rats resulting from 
a 24-hour maternal deprivation period on post-natal day 9. These researchers suggest that 
the 24 hour maternal deprivation "may interfere with hippocampal maturation and this 
may lead to a reduction ofBDNF levels in adulthood as a consequence of changes in 
neurotransmitters or hormones involved in the control of the neurotrophin production" (p. 
613). 
As previously mentioned, BDNF is involved in the formation and maintenance of 
long-term potentiation in the hippocampus (Korte et al. 1995; Johnson, 1999). Studies 
have shown that suppression ofBDNF expression results in deficiencies in hippocampal 
long-term potentiation (Korte et al. 1995; Mu, Li, Yao, & Zhou, 1999). Further, these 
deficiencies can be reversed by acute provision of exogenous BDNF (Patterson, Abel, 
Deuel, Martin, Rose, & Kandel, 1996; Muller, Djebbara-Hannas, Jourdain, Vutskits, 
Durbec, Rougon et al., 2000). 
Manabe (2002) reports that binding ofBDNF to TrkB receptors is vital for 
induction of L TP in the hippocampus. It has also been suggested that BDNF regulates 
long-term potentiation by enhancing synaptic responses to high frequency stimulation 
(Figurov, Pozzo-Miller, Olafsson, Wang, & Lu, 1996; Pozzo-Miller, Gottschalk, Zhang, 
McDermott, Du, Gopalakrishnan, et al., 1999). More specifically, it is believed that 
BDNF promotes long-term potentiation induction via presynaptic mechanisms (Figurov, 
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Pozzo-Miller, Olafsson, Wang, & Lu, 1996; Jovanovic, Czernik, Feinberg, & Greengard, 
2000) by preventing the synaptic fatigue that is induced by the same high frequency 
stimuli that can induce long-term potentiation (Tyler & Pozzo-Miller, 2001). 
Other studies, however, have shown that BDNF also has postsynaptic effects. 
Kovalchuk, Hanse, Kafitz and Konnerth (2002) found an exclusive postsynaptic site of 
Ca2+ signaling in response to BDNF pulses that plays a direct and instructive role in L TP 
induction. 
The Purpose of This Study 
BDNF is a powerful neurotrophic factor that has been implicated in numerous 
neurotransmitter systems, clinical disorders, and spatial abilities. By virtue of its 
relationship to estrogen in particular, it is possible that BDNF may play a role in maternal 
behavior as well. 
In review, rats with reproductive experience learn faster and show an increase in 
neuronal morphological complexity. Both these learning and neuronal changes can come 
about through the effects of estrogen. However, BDNF has effects similar to estrogen on 
neuronal morphology and learning, and previously mentioned studies report that 
deprivation of endogenous BDNF can decrease learning. 
The non-hormonal onset of maternal behavior is arguably a learned behavior in 
virgin rats- it takes about five days of sensitization to pups for these to be initiated 
(Bridges, Zarrow, Gandelman, & Denenberg, 1972). Fleming and Rosenblatt, in 1974, 
reported that after this sensitization period, virgin females will retrieve foster pups, 
engage in licking behaviors, adopt nursing positions, and even build maternal nests. The 
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researchers explain that the quality of these behaviors is different from postpartum rats in 
that inexperienced females do not hold the arched back nursing positions as long and lick 
the foster pups more than the postpartum females. This difference has been explained by 
the different levels of stimulation the rats receive; virgins do not receive the tactile 
stimulation of the pups nursing and therefore do not hold their nursing positions as long, 
and virgins are exposed to pups with distinct odors not her own which would increase 
licking. 
Based on BDNF's involvement with spatial learning, it is possible that exogenous 
BDNF may speed the onset oflearned maternal behavior. To examine ifBDNF plays a 
role in regulating the onset of non-hormonal maternal behavior, this study will add 
exogenous BDNF in virgin females exposed to pups. Neuronal effects will also be 
examined in the medial preoptic area (mPOA) of the hypothalamus, which is known to 
regulate maternal behavior. 
Method 
Animals 
Sixteen age-matched (4-5 months old) virgin female Sprague-Dawley rats 
purchased from Harlan were maintained in accordance with the guidelines of the 
Institutional Animal Care and Use Committee (IA CUC) of the University of Richmond. 
The animals were double housed until surgery, after which they were isolated in 20 x 45 
x 25 cm polypropylene cages with l/8th inch cob bedding covering the floors. Food and 
water were available ad libitum and all animals were housed in light- (on from 0500-1900 
h) and temperature- (21-24°C) controlled testing rooms for the duration of the study. A 
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separate group of age-matched lactating donor rats were maintained to provide pups for 
testing. 
Experimental Groups and Outline of Procedure 
To explore the role ofBDNF in regulating the onset of maternal behavior, we 
used two groups of virgin female rats. The experimental group consisted of eight females 
that received intracerebroventricular infusions ofBDNF sense oligonucleotide to 
supplement the endogenous, or naturally occurring, BDNF. The control group consisted 
of eight females that received infusions of sterile, pyrogen-free physiological saline. 
Studies have shown that exogenous BDNF, when administered into the lateral 
ventricles, has effects that reach circumventricular brain regions. Pencea and colleagues 
(2001) showed neurogenesis in the striatum, septum, thalamus and hypothalamus, 
following 16 days of BDNF infusion into the lateral ventricles of adult rats. Yan, 
Matheson, Sun, Radeke, Feinstein and Miller (1994) also suggest that TrkB receptors line 
the ependymal layer of the ventricles, thus controlling the absorption ofBDNF 
administered intracerebroventricularly. 
Further, previously mentioned studies have shown that the effects of infused 
BDNF sense and antisense on learning can be detected as early as 4 days (Mizuno, 
Yamada, Olariu, Nawa, & Nabeshima, 2000) and 7 days (Pelleymounter, Cullen, Baker, 
Gollub, & Wellman, 1996; Mu, Li, Yao, & Zhou, 1999) after surgical implantation of 
pumps. Based on the findings by Mizuno et al., in this study the testing of maternal 
behavior began on the fourth day after surgery. 
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Foster pups were taken from donor mothers and placed in the home cages of 
virgins to test maternal behavior. After a maximum of 10 days of testing, each virgin 
exposed to pups was sacrificed and her brain removed for analysis of neuronal 
morphology. Please see Appendix A for a flowchart outlining the general sequence of 
events. 
Surgical Procedures and lntracerebroventricular Infusions 
The delivery of experimental and control agents were via osmotic pumps. 
Osmotic pumps are miniature pumps that continuously deliver test agents at controlled 
rates into laboratory animals. The pumps are made of three concentric layers- an outer 
semi-permeable membrane, an osmotic salt sleeve, and a reservoir with an impermeable 
wall. When water crosses the outer semi-permeable membrane, it adds bulk to the salt 
sleeve and compresses the inner reservoir forcing out the test agent. 
The evening before surgeries, pumps were assembled, filled and primed. The 
cannula was attached to an osmotic pump (Alzet model 2002, infusion rate of 0.5 ml/h 
for 14 days, Alza, Palo Alto, CA, USA), following Alzet's instructions, via 3 cm of 
flexible tubing. Although Alzet recommends 12 cm of tubing, we found that the extra 
slack exerted pressure on the cannula that lifted it from the skull. To eliminate this lifting 
and allow the cannula to lie flat on the skull, we shortened the length of the tubing. Pilot 
animals showed no restrictions in movement and appeared comfortable. 
Animals that were infused with BDNF sense received a phosphoth1oate 
oligonucleotide synthesized by Oligos Etc. Inc. (Wilsonville, OR), and purified with high 
performance liquid chromatography. The BDNF sense oligonucleotide sequence was 5'-
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ACCATT AAAAGGGGAAGA-3 '. This sequence was used by Mizuno et al. (2000) and 
was shown by Acheson and colleagues (1995) to have neuron survival effects similar to 
that of exogenous BDNF. Further, a BLAST search was conducted on this sequence upon 
the manufacturer's suggestion to determine if it matched any other sequences. This 
search revealed that the only matches this sequence had were to BDNF genes of various 
species, with the exception of two human chromosome 11 clones. However, because this 
particular oligonucleotide was administered to rats, we believed that it would still have 
the effects Acheson et al. reported. 
Upon arrival, the oligonucleotide was re-suspended in 3.2 ml sterile, pyrogen-free 
physiological saline to a concentration of 3.6nm/d. Experimental pumps were filled with 
the BDNF sense, and control pumps were filled with physiological saline. Filled pumps 
were primed in physiological saline at 37°C for up to 24 hours before surgical 
implantation. 
Surgeries began at 11 :OOam the following morning. Standard stereotaxic 
procedures were followed and all surgical pump implantations were performed as 
aseptically as possible. Each rat was first anesthetized with a mixture ofKetamine and 
Xylazine (at a 50 mg/kg Ketamine and 4 mg/kg Xylazine dosage administered 
intraperitoneally) and placed in a stereotaxic head frame for the implantation of the 
osmotic pump and cannula. After shaving and washing the scalp, a midline sagittal 
incision about 2.5 cm long was made to expose the skull. The skull was scraped to create 
a dry and rough surface for the dental cement to take hold. A hole was drilled in the skull 
BDNF & Maternal Behavior 23 
over the right lateral ventricle, 1.5 mm lateral to the midline and 0.8 mm posterior to 
bregma. 
At this point the previously assembled cannula and pump complex was inserted 
into the animal. The pump was implanted subcutaneoulsy in a previously prepared pocket 
in the subscapular area of the neck. By opening and closing the jaws of a hemostat, the 
subcutaneous tissue was spread to make a 4.0 cm long pocket for the pump. The cannula 
was inserted through the hole into the right lateral ventricle at a depth of 3.5 mm below 
the skull surface. A drop of superglue was used to secure the cannula to the skull while 
the dental cement was mixed, poured over the cannula and skull, and allowed to dry. 
Each animal was sutured (or in the case of three animals, stapled) and the incision 
cleaned with Betadine and treated with the topical antibiotic Neosporin. Immediately 
following surgery, each animal was placed in a clean cage with a lamp over one comer 
and observed until she awoke from the anesthesia. The females were allowed four days to 
recover under post-operative observation, and remained singly housed for the duration of 
the study. 
Assessment of Maternal Behavior 
The onset of maternal behavior was recorded in all groups beginning at 12 noon 
on the fourth day following surgery, using methodological adaptations from Bridges, 
Feder and Rosenblatt (1977). The first step involved priming each rat to the smell of 
pups. To do this, a 50ml beaker-full of bedding from the donor mother's cage was poured 
in the virgin's home cage. After an hour, maternal assessment began, and this priming 
step was not repeated. 
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To begin observing maternal behaviors, the quality of the nest in the virgin's 
home cage was first rated from 1to4 (1=poor,2 =fair, 3 =good, 4 =excellent). After 
this rating, each virgin had 1 recently fed (as determined by the presence of milk bands) 
rat pup placed in her cage. Due to variability, some donors delivered their litters on the 
day testing was supposed to initiate, and so the ages of the pups varied from one to 24 
hours. The responses from each rat were continuously recorded for 15 minutes, and then 
recorded at 30, 45, and 60 minutes after the start of testing. Pup retrieval, grouping and 
crouching were noted, and for the purposes of this study retrieving was assessed as any 
behavior during which the female collected one or more pups away from the nest. 
Grouping was any behavior during which the female placed one or more pups together in 
one spot. Crouching was any behavior during which the mother huddled over one or all 
of the pups. 
After 60 minutes of observation, the rat pup remained in the virgin's home cage 
over night. The following day testing resumed and nest quality was rated and the position 
of the pups and virgin noted. If the virgin female had not cannibalized the one pup, this 
pup was returned to its mother. Each virgin female then had a 15-minute time period after 
the pup(s) were removed during which she had no pups in her cage. After this 15-minute 
period, new recently fed pups were placed in her cage, and the next series of observations 
continued as outlined above. Each virgin received three new pups after the first 24 hour 
period when the virgin did not cannibalize the one pup. 
Criteria for reaching maternal behavior was met once each virgin showed all three 
behaviors in the first 60 minutes of testing for two consecutive days, after which she was 
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sacrificed. If a female failed to reach this criteria within 10 days of testing, the 
observations were terminated and the rat sacrificed. 
Timeline of Surgeries and Testing 
Due to the time consuming nature of serial surgeries and maternal observations, 
this experiment was divided into two rounds. For each round, 4 surgeries a day were 
performed for 2 consecutive days. On day one, the four females were randomly and 
blindly assigned to receive pumps such that one female got BDNF sense and three 
females got saline. On day two, the four females were randomly assigned such that three 
females got BDNF sense and one got saline. This way, there was an equal number of 
experimental and control animals per round of testing. 
Since the behavior testing involved an initial 15 minutes of continuous 
observations, animals were tested serially. This required a complex schedule for priming 
the virgins to pup odors on the first day of testing, and then removing pups, replacing 
pups, observing continuously for the first 15 minutes, and spot-checking for 45 minutes 
afterwards. Please see Appendix B for this testing schedule. 
Brain Tissue Preparation 
After observing maternal behavior, all animals were sacrificed and their brains 
removed for analysis of neuronal morphology using the Golgi-Cox staining procedure. 
The protocol used in this study was an adaptation of the Golgi-Cox technique (Ram6n-
Moliner, 1970) modified for short-term staining (Keyser-Marcus et al., 2001 ). 
Briefly, the brains were blocked in the coronal plane in three sections, beginning 
1.0 mm anterior to the optic chiasm, using a brain matrix, immediately upon removal. 
L 
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The sections were placed in standard Golgi-Cox stain (potassium dichromate and 
mercuric chloride, plus potassium chromate and sodium tungstate in distilled water) for 
approximately 30 days. Subsequently, they were super-glued to a metal chuck, and 
sections were cut using a Vibratome (Series 3000, Technical Products International, Inc., 
St. Louis, MO) into a .9% physiological saline bath. Four sequential 100µ sections were 
taken of the medial preoptic area of the hypothalamus as soon as the anterior commissure 
came together. All sections were placed on "subbed" slides and allowed to dry for 
approximately 20 minutes, after which they were exposed for roughly 5 minutes to the 
alkalizing solution oflithium hydroxide, which reacts with the Golgi-Cox heavy metal 
deposits in the neuron to produce the black product characteristic of the stain. The slides 
were then run through a dehydrating series of alcohols and xylenes, coverslipped, and 
allowed to dry. 
Verification of cannula placement was assessed via histological track marks 
observed during slicing of the brain. All track marks were observed to cut through at least 
part of the corpus callosum above the ventricle. 
Analysis of Neuronal Morphology 
A Zeiss Axioplan microscope fitted to an Optronics color camera and a software 
package expressly designed to trace and record neuronal morphometry ("Bioquant 
Nova," version 5.00.8, R&M Biometrics, Inc., Nashville, TN), was used to measure 
features of neuronal morphology under a total magnification of l,260x. Within the 
mPOA (up to 774 µm from the left or right of the midline, and up to 1,009 µm below the 
anterior commissure ), only neurons with completely stained cell bodies that were easily 
L __ _ 
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discernible from other cells were used. The number of dendritic protrusions was counted 
on the most clearly defined dendrite between the cell body and first branch. Protrusions 
from the dendrite of two kinds were included- either the traditional spines with or without 
bulbous heads as described by Woolley, Gould, Frankfurt and McEwen (1990), or any 
thin, long, filopodia-like extensions. Maletic-Savatic, Malinow and Svoboda (1999) 
suggested that filopodia might mature to become spines and often make synaptic contacts 
in vivo. For this reason, they were included in these analyses. The length of the two 
longest spines per branch was also measured. 
Studies have indicated that the effects of BDNF on neuronal morphology are fast 
acting- in particular, increases in the number of dendrites, as well as increases in their 
length and complexity, have been seen as early as 24 hours (Horeb, Kriittgen, Portbury, 
& Katz, 1999) and 36 hours (McAllister et al. 1995, as cited in McAllister, 1999). Since 
our animals received infusions ofBDNF sense for up to 14 days, we anticipated no 
trouble in detecting any effects ofBDNF manipulation. 
Results 
To first insure that the pumps were working properly, the residual amount oftest 
agents left in the pumps were measured immediately after each animal was sacrificed and 
compared to the amount that should have remained (according to a formula provided by 
Alzet technical support that factored in each pump's flow rate and number of days left in 
the animal). At test revealed no significant difference between the groups, t (14) = .11, 
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p = .91. Further, Pearson product-moment and point-biserial correlations indicated no 
significant relationships between the residual amounts of test agents and any of the 
measures described below. 
Behavioral Data: Maternal Behavior 
Due to the increased variability when looking at days to reach criterion, and in 
keeping with previous research examining latencies to display maternal behavior, a 
Mann-Whitney U test was performed using SPSS to explore the differences in maternal 
behavior between those rats infused with BDNF sense and saline. One animal was 
excluded from this analysis of maternal behavior because she attacked on six consecutive 
days. Separate analyses were run including this animal, but her inclusion in no way 
changed any of the results reported. For the remaining 15 females, the test revealed no 
significant behavioral difference between the groups, Mann-Whitney U = 26.5, p = .429. 
Please see Tables 1 and 2 for descriptive statistics. 
Separate analyses were also run for each individual component of maternal 
behavior. However, there were no significant differences between groups for retrieving 
one pup, Mann-Whitney U = 26.5, p = .43, for retrieving two pups, Mann-Whitney U = 
27.5,p = .48, for retrieving three pups, Mann-Whitney U = 27.5,p = .48, for grouping all 
three pups together, Mann-Whitney U = 26.5,p = .43, nor for crouching over all three 
pups, Mann-Whitney U = 28.0, p = .50. 
Pup attacks during the first 24 hours of pup exposure were also examined for all 
16 animals, including the female that attacked on six consecutive days. A chi square test 
was performed using SPSS and it revealed a significant effect of BDNF on decreasing 
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attacks, X2 (1) = 4.00, p < .05. As predicted, more control females attacked during the 
first 24 hours of pup exposure (6 out of 8; 75%) than did BDNF females (2 out of 8; 
25%). Please see Figure 3. 
Neuronal Data: Medial Preoptic Area 
Within the mPOA, neurons were studied for their number of dendritic protrusions 
as well as the length of the two longest protrusions on each branch measured. Protrusions 
were counted on the principal dendrite between the cell body and first branch, and the 
length of that dendritic branch was measured using Bioquant. It has been reported that in 
mPOA neurons in the majority of adult (90 days) rats the first 10-30 µm long portion of 
dendrites are devoid of protrusions (Gerocs, Rethelyi, & Halasz, 1986). The dendritic 
branches we measured were on average 84.51 µmin length, but they ranged from 19.87 
µm to 281.64 µm. 
Following Woolley and McEwen's (1993) data analysis methodology, the length 
of the branch was divided by 10, and the number of spines was divided into that number, 
yielding a numerical value for the number of protrusions per 10 µm of dendritic branch. 
These values were then averaged for each animal. The lengths of the two longest 
protrusions per branch for all the branches measured in each animal were also averaged 
together. 
One branch was examined per neuron, two neurons were examined per tissue 
section, and four sections were taken per animal, resulting in a maximum total of 8 
neurons per animal. However, due to staining difficulties, it was possible to get data on 
only 4 animals per experimental group. Further, the lack of full Golgi impregnation left 
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one animal in each group with less than 8 data values- one animal in the control group 
only had 3 data values averaged together, and one animal in the BDNF group only had 6 
data values averaged together. 
A one-way independent samples t test was performed using SPSS to explore the 
differences in dendritic protrusion number between those rats infused with BDNF sense 
and saline. Again, one animal was excluded, as she attacked on six consecutive days. 
This test revealed that BDNF had a significant effect on dendritic protrusion number, t 
(6) = -2.09,p < .05. As predicted, neurons of rats infused with BDNF had more 
protrusions per 10 µm of dendritic branch (M = 2.96, SD = .56) than did those neurons of 
control rats (M= 1.84, SD= .91). Please see Figures 4 and 5. 
A similar one-way independent samples t test was also performed to explore the 
differences in dendritic protrusion length between both groups. This test revealed that 
BDNF had no effect on the average length of protrusions per branch, t (6) = -.24,p = .41. 
Please see Table 3. 
Behavioral Data for the Females that had Neuronal Data 
Once the differences in protrusions density mentioned above were found, the 
behaviors of the animals from which neuronal data were derived were re-analyzed. 
Within this smaller sub-sample of four rats per group, a Mann-Whitney U test again 
revealed no significant effect ofBDNF on maternal behavior, Mann-Whitney U = 3.0, 
p = .06. Please see Table 4. Further, the previously established difference in attack 
behaviors was not preserved, X2 (1) = .00, p = 1.0, as an equal number of rats attacked 
and did not attack in both groups. Please see Table 5. 
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Correlations were also run to examine if there was a relationship between 
dendritic protrusion density and maternal behavior or the number of attacks (please see 
Table 6). Pearson product-moment correlations revealed no significant relationships 
between protrusion density and maternal behavior in control animals, r = -.604, p = .396; 
or in BDNF-infused animals, r = -.836, p = .164. However, point-biserial correlations 
revealed that within the 4 control animals there was as significant relationship between 
protrusion density and attacks, such that animals with higher numbers of protrusions per 
10 µm branch attacked less, rpb = -.984, p < .05. This relationship was not significant for 
the 4 BDNF-infused animals though, rpb = .540,p = .460. 
Discussion 
Summary of Findings 
Behaviorally, BDNF sense had no effect on facilitating maternal behavior but did 
significantly suppress pup attacks during the first 24 hours of exposure. BDNF had a 
significant effect on neuronal morphology in the mPOA as well, such that mPOA neurons 
exposed to BDNF had more dendritic protrusions per 10 µm of dendritic branch than did 
control neurons. However, the length of the two longest dendritic protrusions on each 
branch measured was not affected by BDNF sense. Within the animals for which 
neuronal data was obtained, there was no significant difference between groups on 
maternal behavior or attacks. However, for the 4 control animals, there was a significant 
relationship between protrusion density and attacks, such that animals with higher 
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numbers of protrusions per 10 µm branch attacked less. This relationship was not present 
in the 4 BDNF-infused animals. 
Discussion of Findings 
Finding differences in pup attacks despite no differences in maternal behavior is 
interesting as it suggests that pup attacks and maternal behavior may rely on separate 
mechanisms or brain regions. Kimble, Rogers, and Hendrickson (1967) examined the 
effects of hippocampal lesions on maternal behavior and reported some interesting 
findings that shed light on the pup attack differences observed here. They reported that 
following bilateral aspiration lesions of the hippocampus, female rats that had given birth 
showed significantly increased rates of cannibalism, time spent exploring (as opposed to 
nursing), and inferior nest-building skills, as compared to control mothers. Hippocampal-
lesioned mothers also generally failed to hover over their pups, or if they did, they 
hovered several inches away from any of the pups. Keeping in mind that our rats did not 
experience pregnancy, parturition or lactation, and did not have hippocampal damage, the 
fact that hippocampal lesioning had differential effects on different aspects of maternal 
behavior is of particular interest because it suggests a division among maternal behaviors; 
different aspects of maternal behavior may be regulated by different brain regions. 
Indeed, a number of studies show that different brain regions regulate different 
aspects of maternal behavior (please see Table 7). Kimble, Rogers and Hendrickson, 
specifically, implicated the hippocampus in increased rates of cannibalism. This fits with 
the data reported in this study, as it suggests that the actions ofBDNF on neuronal 
morphology in the mPOA are independent ofBDNF's suppressive nature on pup attacks. 
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Further, research is starting to identify a neural circuit involved in the inhibition 
of maternal behavior in virgin rats. Sheehan, Cirrito, Numan and Numan (2000) have 
identified various regions they believe to inhibit maternal behavior: the anterior 
hypothalamic nucleus, the principal bed nucleus of the stria terminalis, the ventral 
subdivision of the lateral septum, the posterodorsal medial amygdala, the ventrolateral 
medial preoptic area, the dorsal premammillary nucleus, the parvocellular paraventricular 
nucleus of the hypothalamus, and the dorsomedial and ventral regions of the 
ventromedial nucleus of the hypothalamus. Sheehan and colleagues believe that the 
hormonal environment of pregnancy actually decreases pup-induced neural activity in 
these brain regions, thus inducing maternal behavior. 
Finding protrusion density differences despite the lack of behavioral differences is 
intriguing and strengthens the argument that maternal behavior is steroid dependent. It 
has been shown that BDNF sense alone cannot exert changes in spatial learning behavior 
(Mizuno et al., 2000), despite its documented ability to enhance sprouting (Kesslak, So, 
Choi, Cotman, and Gomez-Pinilla, 1998). The same dichotomous actions ofBDNF may 
hold true for maternal behavior, especially in light of work done by Bridges, Numan, 
Ronsheim, Mann, and Lupini (1990) showing that prolactin's stimulation of maternal 
behavior is steroid dependent. These researchers showed that infusions of prolactin into 
the lateral ventricle failed to stimulate maternal behavior in nonsteroid-treated rats, 
whereas the same dose of prolactin given with estrogen and progesterone did stimulate 
the behavior. It is possible that even though BDNF alone may stimulate dendritic 
protrusion formation in the mPOA, BDNF sense may have to be administered with 
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estrogen and progesterone levels similar to those of pregnancy to stimulate maternal 
behavior. 
Furthermore, finding neuronal differences in the mPOA that did not translate into 
maternal behavior also fits with the theory described by Numan (1994) that the mPOA is 
a site where hormones act to influence maternal behavior. Numan summarizes previous 
literature and describes how the mPOA is packed with estrogen- and progesterone-
binding receptors, and how the rising levels of estradiol during late pregnancy are thought 
to bind to these receptors and stimulate protein synthesis. This protein synthesis is then 
thought to affect neurotransmitter levels and possibly change mPOA neural activity in a 
way that promotes maternal behavior. Our findings are in keeping with this theory-
BDNF has been shown to alter neurotransmitter synthesis and release, and in this study 
enhanced the dendritic protrusion density of mPOA neurons. Further, our failure to see a 
change in maternal behavior may be due to a lack of pregnancy-like levels of estrogen 
and progesterone. The mPOA may have been primed for the behavior but needed the 
hormones to actually make the behavior occur, as in the work done by Bridges and 
colleagues in 1990. 
Perhaps the most intriguing finding was that within the control animals that had 
neuronal data, there was a relationship between protrusion density and attacks. This 
suggests that having more protrusions suppresses pup attacks. Our BDNF-infused 
animals had increased levels of spines and thus no effect was seen on pup attacks- though 
it is important to note that in the BDNF group of four animals, 2 attacked and 2 did not. It 
is possible that for this reason the correlation was not significant. However, these 
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findings may still suggest that cannibalism, one aspect of maternal behavior, is not 
steroid dependent. 
Connections to the Hormones of Pregnancy 
As previously mentioned, BDNF is influenced by fluctuating hormones (Gibbs, 
1998), as well as estrogen replacement therapy (Singh, Meyer, & Simpkins, 1995; 
Sohrabji et al., 1995; Gibbs, 1998). Progesterone too has been shown to affect levels of 
BDNF mRNA and protein. Gibbs (1999) reported that acute treatment of ovariectomized 
females with estrogen and progesterone produces a significant increase in BDNF mRNA 
and protein in the pyriform cortex. In the hippocampus however, results were different. 
Females killed 72 hours after receiving estrogen and 24 hours after receiving 
progesterone showed a significant increase in BDNF mRNA. A smaller increase was 
detected in animals killed after 53 hours of receiving estrogen alone, but there was no 
significant effect noted in animals killed after 53 hours of receiving estrogen and 5 hours 
after receiving progesterone. These findings indicate that estrogen and progesterone 
interact with each other in altering BDNF levels. 
Oxytocin is another hormone that has been recently implicated in learning and 
memory processes in the hippocampus. Intracerebroventricular injections of oxytocin 
have been shown to enhance long-term synaptic plasticity as well as long-term memory 
through the activation of the MAP kinase cascade and the CREB phosphorylation that 
follows in virgin mice (Tomizawa, Iga, Lu, Moriwaki, Matsushita, Li, et al., 2003). 
Linking their findings to the previously mentioned study reporting that rats with 
reproductive experience learn faster (Kinsley et al., 1999), Tomizawa and colleagues 
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indicate that reproductive experience strikingly changes a female's biochemical 
environment- oxytocin is released through pup stimulation and oxytocin's improvement 
in spatial memory is important in ensuring pups' survival and development. 
Further, Tomizawa et al. (2003) report that oxytocin receptors were strongly 
expressed in the hippocampus, but that their expression level did not change through 
development and pregnancy. However since estrogen and progesterone, as these 
researchers report, have been shown to change oxytocin receptor expression levels in 
other brain regions, this apparent differential regulation of receptor expression in 
response to sex hormones remains to be determined. As BDNF is influenced by estrogen 
and progesterone, it is also possible that BDNF and oxytocin have a dual relationship. 
This, however, has not yet been investigated. 
BDNF is a protein so entwined in different systems and hormones that its role in 
maternal behavior and reproductive experience should not go un-investigated. 
Limitations 
This experiment is not without its limitations. The brains of the second round of 
animals tested were not fully impregnated with Golgi, despite having remained in 
solution for approximately 30 days just as the first round of brains had. These staining 
difficulties halved our sample size for the analysis of neuronal morphology, and the small 
number of animals per group may have prevented us from observing the full effects of 
BDNF sense. 
Our definition and quantification of protrusions may have been too general as 
well. We included filopodia in our analyses, and future studies may wantto be more 
BDNF & Maternal Behavior 37 
restrictive in their identification of spines. It is possible that the effects of BDNF sense 
are different if only spines are measured. It would also be interesting to determine 
whether or not the filopodia we observed would develop into spines with more exposure 
to BDNF, as it is probable that our brains were removed midway through a process of 
change for the mPOA neurons. Further, the region we considered to be mPOA may have 
been too broad; the effects reported here may not be replicated in a smaller, more strictly 
defined region. 
The fact that there were no differences between groups in maternal behavior may 
be a result of various factors. First, there was no way of verifying whether or not the 
BDNF sense was functioning in vivo. Oligos Etc. Inc. did provide a synthesis and 
analysis report, and although all precautions were taken to avoid contamination, we are 
not sure if the oligonucleotide was contaminated during transportation, re-suspension, or 
filling of the pumps. However, because neuronal differences were found in the present 
work, it can be argued that the BDNF was indeed functioning properly and to its fullest 
potency. 
Second, some of the pups were only hours old and may have had stronger, even 
more aversive, odors due to the presence of blood and amniotic fluids. Grota (1973) 
conducted an elaborate experiment in which he manipulated the delivery of pups (normal 
or surgical), whether or not the pups were washed or had amniotic fluids, and whether or 
not the foster mother was injected with placental homogenate. He reported that both 
normally and surgically delivered pups that had been washed with .9% physiological 
saline had a 78% survival rate. Surgically delivered and washed pups had a 100% 
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survival rate when the foster mothers had been injected with placental homogenates. Both 
normally and surgically delivered pups that had been immersed in amniotic fluids had a 
66% survival rate, however, when the foster mother had been injected with placental 
homogenates none of the normally delivered pups survived, and only 39% of the 
surgically delivered pups survived. Grota suggested that pup survival depends on the 
interaction of both the fluids surrounding pups at fostering, as well as the substances 
present in the placenta and liver. Grota used lactating females as foster mothers, and the 
hormones of pregnancy could play a significant role in the findings he reported. Although 
we used virgin females, the presence of amniotic fluid on some of the pups may have 
interacted with the onset of their maternal behaviors. 
Third, the animals used in this study were cycling females. It has been well 
documented that densities of hippocampal dendritic spines fluctuate naturally during the 
rat's 5-day estrous cycle (Woolley, Gould, Frankfurt, & McEwen, 1990; Woolley & 
McEwen, 1992). It is thus possible that the waxing and waning in spine densities that the 
fluctuating hormone levels may have caused could have occluded any of the effects of 
BDNF itself. However, Murphy, Cole and Segal (1998) showed that exogenous BDNF 
suppressed estradiol's effect on spine density and even had a small effect of its own to 
reduce dendritic spine density in hippocampal cultures. It can therefore be argued that in 
this study, BDNF was able to override the dendritic spine density fluctuations associated 
with the estrous cycle, and that the increased number of protrusions that we observed was 
in fact due to the manipulation ofBDNF and not to the rat's estrous cycle. However, it is 
still possible that the hormonal fluctuations occluded BDNF's effect (if any) on maternal 
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behavior. Further, we did not smear our females at any point, so there was no knowledge 
of what stage of the estrous cycle the rats were in at various points throughout the study. 
Future studies should nonetheless control for these hormonal fluctuations by using 
ovariectomized females, or ovariectomized females receiving estrogen and progesterone. 
Fourth, this study only examined retrieving, grouping and crouching. Maternal 
behavior is composed of a host of other behavioral aspects, such as avoidance, licking, 
nest building, time spent in the nest, etc., that may have been differentially affected by 
BDNF. 
Further work should be done to replicate these findings and improve on some of 
our methods by, for example, increasing the sample size, using ovariectomized females 
(or ovariectomized females with estrogen and progesterone), tighten the definition of 
dendritic spines and examine other aspects of maternal behavior. 
Future Research 
Should BDNF prove to be an important factor in speeding the onset of maternal 
behavior in virgin rats, it would be important to further explore the current findings. One 
aspect of inquiry would be whether BDNF has its effects on the maternal behavior of post 
partum rats. To find this out, a similar study can be conducted in which animals receive 
infusions of BDNF sense, antisense and saline during the last week of pregnancy and first 
week of lactation. In addition to this, one could further examine whether BDNF has an 
effect on maternal behavior during pregnancy, lactation or both. It is possible that these 
different stages affect different aspects of maternal behavior. To explore this idea, some 
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rats can be infused with BDNF sense or antisense only during pregnancy and not during 
lactation, and other rats can be infused only during lactation. 
Implications for BDNF and Post-Partum Depression I Infanticide 
Should BDNF prove to be an important factor in speeding the onset of maternal 
behavior in virgin rats the implications would be far-reaching. The results could open the 
doors to further work with BDNF in the realm of the behavioral symptomatology of post-
partum depression. Research has shown that intracerebral administration ofBDNF to 
animals may have antidepressant properties. Using the learned helplessness and forced 
swim animal models of depression, Siuciak, Lewis, Wiegand and Lindsay (1997) 
reported that BDNF infusion in rats produced anti-depressant like effects. Vehicle-
infused rats exposed to the inescapable foot shock of the learned helplessness paradigm 
showed escape deficits. These deficits were reversed by chronic BDNF infusion. Further, 
BDNF infusion also decreased the immobility time by 70% in the forced swim task, as 
compared to vehicle infusion. 
BDNF expression also plays an important role in the clinical response to 
antidepressant treatment (Russo-Neustadt, Ha, Ramirez, and Kesslak, 2001). Altar (1999) 
suggests that antidepressant medications and even electroconvulsive shock therapy may 
work by boosting the brain's production ofBDNF. 
A strong presence ofBDNF during pregnancy may prove protective to a female, 
such that she is in less risk of developing depression. BDNF may also be adversely 
affected during the rapid and sudden decrease in hormones that occurs at parturition and 
negatively affect a female. BDNF may thus play a role in post partum depression. 
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The fact that we found differences in pup attacks in our total sample of rats may 
also indicate a role for BDNF in decreasing post-partum infanticide. While BDNF has not 
previously been studied in relation to maternal behavior, our findings do show that 
females receiving BDNF sense attacked pups significantly less during the first 24 hours 
of pup exposure. Although it may be possible that BDNF had a direct effect on 
decreasing cannibalism, it more likely affected areas of the brain that we did not look at, 
which do influence cannibalism. Kimble, Rogers and Hendrickson's 1967 study, 
implicated the hippocampus in increased rates of cannibalism- it is possible that BDNF 
affected hippocampal neurons and thus altered this aspect of maternal behavior via this 
route. 
Implications for BDNF and Alzheimer's Disease 
As previously discussed, BDNF and estrogen are closely linked in terms of their 
neuroprotective effects. Alzheimer's disease is an example of an area of interest in which 
estrogen and BDNF's roles have been explored in a number of ways, but with mixed 
results. For example, decreased levels ofBDNF have been reported in the hippocampus 
and parietal cortex of patients with Alzheimer's disease (Hock, Heese, Hulette, 
Rosenberg & Otten, 2000; Holsinger, Schnarr, Henry, Castelo & Fahnestock, 2000). 
However, other studies have shown an opposite increase ofBDNF levels in patients with 
Alzheimer's disease (Durany, Michel, Kurt, Cruz-Sanchez, Cerv6s-Navarro, & Riederer, 
2000). 
Similarly, administration of estrogen to patients with Alzheimer's has been shown 
to improve some aspects of cognition related to this disease (Brinton, Chen, Montoya, 
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Hsieh, Minaya, Kim, et al., 2000; Asthana et al., 2001), but also has reportedly failed to 
improve these aspects of cognition (Mulnard, Cotman, Kawas, van Dyck, Sano, Doody et 
al., 2000). Recent findings even indicate that estrogen plus progestin therapy increases 
the risk of developing dementia and does not prevent mild cognitive impairment in 
postmenopausal women (Shumaker, Legault, Rapp, Thal, Wallace, Ockene et al., 2003). 
However, these equivocal findings could be due to methodological confounds. 
Research in this lab also promotes further exploration of the link between BDNF 
and Alzheimer's disease. Gatewood (2002) examined the levels of amyloid precursor 
protein (APP; a protein that plays an important role in the early stages of 
neurodegeneration associated with Alzheimer's disease) in the hippocampus and dentate 
gyros of aged (24 months) rats with differing levels of reproductive experience. 
Gatewood found that in the CAI area of the hippocampus multiparous rats had 
significantly fewer APP immunoreactive cells than did either nulliparous or primiparous 
rats. This significant difference, however, was revealed upon post hoc analysis of a non-
significant F value. Gatewood also found that in the dentate gyros, multiparous animals 
had significantly fewer APP immunoreactive cells than did nulliparous rats, but no other 
significant differences were noted. 
Gatewood's study provides strong support for the notion that reproductive 
experience provides long-lasting neuroprotective properties. BDNF, with its role in 
neuroplasticity and its link to estrogen, may be an important neurochemical link 
responsible for these effects. Berchtold, Kesslak, Pike, Adlard, & Cotman (1995) have 
suggested that some of the beneficial effects of estrogen may in fact be due to increased 
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availability ofBDNF. Thus BDNF may function as an important step involved in 
treatment programs such as estrogen replacement. 
Implications for BDNF and Huntington 's Disease 
BDNF has even been implicated in playing a therapeutic role in the treatment of 
Huntington's disease (Zuccato, Ciammola, Rigamonti, Leavitt, Goffredo, Conti, et al., 
2001). Interestingly, preliminary DNA microarray data collected by this lab have shown 
that lactating females express the Huntington's disease mRNA gene 2.8 times more than 
do nulliparous females. The actions of this gene have yet to be examined, but the 
increased expression in lactating versus nulliparous females may point to a long-lasting, 
potentially beneficial and protective, effect of reproductive experience on the females' 
brains. BDNF and estrogen may work together in mediating this neuroprotective effect. 
BDNF as a Promising Therapeutic Agent 
BDNF has recently been modified to cross the blood-brain barrier, which has 
opened the doors to its potentially more accessible use as a therapeutic agent. Stroke 
research (Wu & Pardridge, 1999; Zhang & Pardridge, 2001) has shown that intravenous 
administration ofBDNF conjugated to the OX26 murine monoclonal antibody 
(BDNF/OX26) normalized hippocampal CAI neuronal density, and reduced cortical 
stroke volume at both 24 hours and 7 days by 68% and 70% respectively. The 
neuroprotection was long lasting, as it persisted for at least 7 days after a I-hour middle 
cerebral artery occlusion. 
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BDNF's conjugation to a blood-brain barrier drug targeting system could lead to 
the systemic administration of BDNF for many purposes. The neuroprotective and 
memory-related effects ofBDNF may thus become more widely and painlessly available. 
Concluding Remarks 
Despite its limitations, this study provides evidence that BDNF sense, when 
administered centrally into virgin females, increases dendritic protrusion density and 
suppresses cannibalism during the first 24 hours of pup exposure. These findings add 
another piece to the puzzle of maternal behavior, opening the doors to a new line of 
research in the field. BDNF has not yet been studied in relation to maternal behavior, and 
this pioneering study points to its potential role in bolh suppressing one aspect of the 
behavior (cannibalism), and in priming the mPOA for maternal behaviors to occur. 
Future research should explore lhe significance of lhese findings, as well as the 
mechanisms by which BDNF exerts the effects we report. 
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Table 1 
Maternal Behavior Data: Days to Reach Criteria 
Group N Range Mean (SD) Median 
BDNF 8 4-10 7.63 (1.85) 7.5 
Control 7 6-10 7.71 (1.89) 7 
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Table 2 
Range Distribution for the Number of Animals in Each Group That Reached Maternal 
Behavior Criteria Based on Day of Testing 
Days of Testing 
Group 1-2 3-4 5-6 7-8 9-10 
BDNF 0 0 4 3 
Control 0 0 3 3 
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Table 3 
Average Length in Microns of the Two Longest Spines in the Medial Preoptic Area of the 
Hypothalamus 
Group N Mean (SD) 
BDNF 4 1.32 (.35) 
Control 4 1.26 (.45) 
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Table 4 
Maternal Behavior Data for the 8 Animals that had Neuronal Data: Days to Reach 
Criteria 
Group N Range 
BDNF 4 7-9 
Control 4 6-9 
Mean (SD) 
8.25 (0.96) 
6.75 (1.50) 
Median 
8.5 
6 
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Table 5 
Pup Attacks for the 8 Animals that had Neuronal Data During the First 24 Hours of Pup 
Exposure 
Group 
BDNF 
Control 
Attacks 
Yes 
2 
2 
No 
2 
2 
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Table 6 
Pearson Product Moment and Point-Biserial Correlations Between Neuronal and 
Behavioral Effects for the Animals with mPOA Data 
Days to Reach Maternal Pup Attacks During the First 
Group Behavior 24 Hours of Exposure 
Controls (n = 4) 
#of Protrusions -.604 -.984* 
BDNF (n=4) 
# of Protrusions -.836 .540 
* p < .05 
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Table 7 
A Summary of Studies Showing How Damage to Different Brain Regions Affects Different 
Aspects of Maternal Behavior 
Brain Region 
Hippocampus* 
Aspect of Behavior Disrupted by Lesions (Reference) 
Cannibalism, nest building, nursing, & retrieving 
(Kimble, Rogers & Hendrickson, 1967) 
Fimbria Nest building & retrieving (Terlecki & Sainsbury, 1978) 
Periaqueductal Gray Nursing (Stem & Lonstein, 2001) 
Neocortex* Nest building, nursing, & retrieving (Beach, 1937; In 
Numan, 1994) 
Medial Cortex Retrieving (Stamm, 1955; Slotnick, 1967; Wilsoncroft, 
1963; All in Numan, 1994) 
Septum Retrieving (Fleischer & Slotnick, 1978; In Numan, 1994) 
Medial Preoptic Area Nest building, nursing, & retrieving, (Numerous studies 
cited in Numan, 1994) 
* BDNF has been observed in this brain region 
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Figure Captions 
Figure 1. Estrous Cycle of the Rat 
Figure 2. Hormonal Pattern of Pregnancy in the Rat 
Figure 3. Percentage of Females that Attacked During the First 24 Hours of Pup 
Exposure 
Figure 4. Mean Number ofDendritic Protrusions per 10 µm ofDendritic Branch 
Figure 5. Photomicrographs of Representative Neurons that Received BDNF Sense and 
Control Neurons at a Total Magnification of l,260x 
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Estrous Cycle of the Rat• 
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*Adapted from Nelson, R. J. (1995). Female Reproductive Behavior (p. 273). In An 
Introduction to Behavioral Endocrinology. Sunderland, MA: Sinauer Associates, Inc. 
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Hormonal Pattern of Pregnancy in the Rat· 
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Percentage of Females that Attacked During the First 24 Hours 
of Pup Exposure 
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Mean Number of Dendritic Spines per 10 µm 
ofDendritic Branch 
* 
Control BDNF 
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Photomicrographs of Representative BDNF Sense Infused Neurons 
and Control Neurons at a Total Magnification of l ,260x 
BDNFNeuron Control Neuron 
Scale Bars = 6 µm 
General Sequence of Events: 
~ 
16 Virgin 
females are 
randomly 
divided into 
2 groups. 
--------------. 
Surgery: 8 females 
receive pumps with 
BDNF sense 
oligonucleotide. 
Infusions begin 
at this point. 
(0.5 ml/h for 14 days) 
Surgery: 8 females 
receive pumps with 
saline. 
Infusions begin at 
this point. 
(0.5 ml/h for 14 days) 
Day 1 of Experiment 
Appendix A 
/ 
Virgins Exposed to pups. 
Testing for Maternal 
Behaviors Begins. 
Day 4 of Experiment 
-...., 
.... 
.... Animals 
Killed 
-Day 14 of Experime1 
AppendixB 
Schedule of Events for Maternal Behavior Testing: 
Day 1 Day2 Days 3 - 10 
Time Prime Test Spot Check Prime Remove Test Spot Check Remove Test Spot Check 
11:15am 1 and2 
11:30am 3 and4 
11:45am 5 and 6 
12:00pm 7 and 8 1 and2 1and2 
12:15pm 1 and2 3 and4 1 and2 3 and4 1 and2 
12:30pm 3 and4 3 and4 5 and6 3 and4 
12:45pm 1 and2 5 and6 1 and2 7 and 8 5 and 6 1and2 
l:OOpm 1, 2, 3 & 4 7 and 8 1, 2, 3 & 4 7 and 8 1, 2, 3 & 4 
1:15pm 1, 2, 3 & 4 1, 2, 3, 4, 5 & 6 1, 2, 3, 4, 5 & 6 
1:30pm 3 and4 3, 4, 5, 6, 7 & 8 3, 4, 5, 6, 7 & 8 
1:45pm 5, 6, 7, & 8 5, 6, 7 & 8 
2:00pm 7 and 8 7 and 8 
